News
CollPlant Biotechnologies , a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived, rhCollagen for tissue regeneration and ...
Adjusted EBITDA Strong revenue growth together with Global Blue's high operating leverage profile resulted in an Adjusted EBITDA of €48.5 million, a 43% year-over-year increase. Adjusted EBITDA margin ...
Group revenue rose 20% YoY, reaching €508 million and reflecting robust growth Record-breaking Adjusted EBITDA(1) of €202m, delivering a 36% YoY increase, in line with the financial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback